Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Lu Yu Kuo, Zhong Li Titus Lim, Caitlin Letch, Joshua Silverman, Jason Jae Yeun Kim, Scott McClintock |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
A multicentre retrospective analysis of anterior urethroplasty techniques and outcomes for urethral stricture disease secondary to transurethral resection of the prostate
por: Łukasz Białek, et al.
Publicado: (2026)
por: Łukasz Białek, et al.
Publicado: (2026)
A systematic review and network meta‐analysis comparing Rezūm with transurethral needle ablation and microwave thermotherapy for the management of enlarged prostate
por: Ansh Bhatia, et al.
Publicado: (2024)
por: Ansh Bhatia, et al.
Publicado: (2024)
Emerging tools for the early detection of prostate cancer
por: Muhammad Haider, et al.
Publicado: (2025)
por: Muhammad Haider, et al.
Publicado: (2025)
Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
por: Angelo Porreca, et al.
Publicado: (2025)
por: Angelo Porreca, et al.
Publicado: (2025)
Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
por: Ruth Pidsley, et al.
Publicado: (2024)
por: Ruth Pidsley, et al.
Publicado: (2024)
Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
por: Ansh Bhatia, et al.
Publicado: (2024)
por: Ansh Bhatia, et al.
Publicado: (2024)
Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
por: Sean Lim, et al.
Publicado: (2024)
por: Sean Lim, et al.
Publicado: (2024)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
por: Chase Peng Yun Ng, et al.
Publicado: (2025)
A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
por: Renil S. Titus, et al.
Publicado: (2025)
por: Renil S. Titus, et al.
Publicado: (2025)
Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)
AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
por: Muhammad Imran, et al.
Publicado: (2026)
por: Muhammad Imran, et al.
Publicado: (2026)
Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
por: Eric Margolis, et al.
Publicado: (2025)
por: Eric Margolis, et al.
Publicado: (2025)
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
por: Mathew Thakur, et al.
Publicado: (2024)
por: Mathew Thakur, et al.
Publicado: (2024)
Comparison of perioperative bleeding risk between direct oral anticoagulants in transurethral resection of prostate
por: Lu Yu Kuo, et al.
Publicado: (2024)
por: Lu Yu Kuo, et al.
Publicado: (2024)
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
por: Esther H. J. Hamoen, et al.
Publicado: (2025)
por: Esther H. J. Hamoen, et al.
Publicado: (2025)
Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
por: Alan Priester, et al.
Publicado: (2024)
por: Alan Priester, et al.
Publicado: (2024)
The carbon footprint of transperineal prostate biopsy
por: Daniel A. Carson, et al.
Publicado: (2025)
por: Daniel A. Carson, et al.
Publicado: (2025)
Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
por: Samantha Shekar, et al.
Publicado: (2025)
por: Samantha Shekar, et al.
Publicado: (2025)
Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
por: Sophia M. Abusamra, et al.
Publicado: (2025)
por: Sophia M. Abusamra, et al.
Publicado: (2025)
Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)
por: Abel Tesfai, et al.
Publicado: (2024)
Bibliometric analysis of focal therapy in prostate cancer research
por: Mohammed Shahait, et al.
Publicado: (2024)
por: Mohammed Shahait, et al.
Publicado: (2024)
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
por: Hugo Klempfner, et al.
Publicado: (2024)
por: Hugo Klempfner, et al.
Publicado: (2024)
‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
por: Ryan Sutherland, et al.
Publicado: (2024)
por: Ryan Sutherland, et al.
Publicado: (2024)
Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
por: Ailene E. Corona, et al.
Publicado: (2026)
por: Ailene E. Corona, et al.
Publicado: (2026)
The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
por: André B. Silva, et al.
Publicado: (2026)
por: André B. Silva, et al.
Publicado: (2026)
Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
por: Eric V. Li, et al.
Publicado: (2024)
por: Eric V. Li, et al.
Publicado: (2024)
National survey of urologists' views on prostate cancer screening in the United Kingdom
por: Nikhil Mayor, et al.
Publicado: (2026)
por: Nikhil Mayor, et al.
Publicado: (2026)
Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
por: Nadia Rokan, et al.
Publicado: (2025)
por: Nadia Rokan, et al.
Publicado: (2025)
Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
por: Emilien Seizilles de Mazancourt, et al.
Publicado: (2025)
por: Emilien Seizilles de Mazancourt, et al.
Publicado: (2025)
WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
por: Mohamad Baker Berjaoui, et al.
Publicado: (2024)
por: Mohamad Baker Berjaoui, et al.
Publicado: (2024)
The significant costs of prostate cancer management—An analysis from a Caribbean hospital
por: Geneva Pantoja, et al.
Publicado: (2025)
por: Geneva Pantoja, et al.
Publicado: (2025)
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)
por: Sofia Mesquita, et al.
Publicado: (2025)
Risk factors of negative prostate biopsies: A CHAID decision tree analysis
por: Pierre Allainguillaume, et al.
Publicado: (2026)
por: Pierre Allainguillaume, et al.
Publicado: (2026)
Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
por: Jeremy Cheng, et al.
Publicado: (2025)
por: Jeremy Cheng, et al.
Publicado: (2025)
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
por: Jonathon Dawson, et al.
Publicado: (2024)
por: Jonathon Dawson, et al.
Publicado: (2024)
A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
por: Marcus Sondermann, et al.
Publicado: (2025)
por: Marcus Sondermann, et al.
Publicado: (2025)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
por: Muhammad Haider, et al.
Publicado: (2025)
por: Muhammad Haider, et al.
Publicado: (2025)
Potential gains from radical treatment of men with prostate cancer according to life expectancy
por: Sandra Irenaeus, et al.
Publicado: (2025)
por: Sandra Irenaeus, et al.
Publicado: (2025)
Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
por: Austin Drysch, et al.
Publicado: (2025)
por: Austin Drysch, et al.
Publicado: (2025)
Ejemplares similares
-
A multicentre retrospective analysis of anterior urethroplasty techniques and outcomes for urethral stricture disease secondary to transurethral resection of the prostate
por: Łukasz Białek, et al.
Publicado: (2026) -
A systematic review and network meta‐analysis comparing Rezūm with transurethral needle ablation and microwave thermotherapy for the management of enlarged prostate
por: Ansh Bhatia, et al.
Publicado: (2024) -
Emerging tools for the early detection of prostate cancer
por: Muhammad Haider, et al.
Publicado: (2025) -
Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
por: Angelo Porreca, et al.
Publicado: (2025) -
Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
por: Ruth Pidsley, et al.
Publicado: (2024)